In patients with breast cancer, the administration of doxorubicin and trastuzumab is associated with an increased risk of cardiotoxicity. Although multiple-gated acquisition (MUGA) scans and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback